Literature DB >> 16757495

Serum cholesterol, haemorrhagic stroke, ischaemic stroke, and myocardial infarction: Korean national health system prospective cohort study.

Shah Ebrahim1, Joohon Sung, Yun-Mi Song, Robert L Ferrer, Debbie A Lawlor, George Davey Smith.   

Abstract

OBJECTIVE: To investigate risk factors, such as heavy alcohol consumption, that might explain any increased risk of haemorrhagic stroke associated with low blood cholesterol.
DESIGN: Prospective cohort study.
SETTING: Korea. PARTICIPANTS: 787,442 civil servants (661,700 men, 125,742 women) aged 30-64. MAIN OUTCOME MEASURES: Cardiovascular risk factors were assessed at biennial health check. Data on morbidity and mortality were ascertained from 1990 to 2001 using hospital admissions and mortality surveillance systems.
RESULTS: 6328 cases of ischaemic stroke (6021 men, 307 women), 3947 cases of haemorrhagic stroke (3748 men, 199 women), 3170 cases of undefined stroke (2902 men, 268 women), and 4417 cases of myocardial infarction (4305 men, 112 women) occurred. Ischaemic stroke and myocardial infarction were strongly and positively associated with blood cholesterol (hazard ratio per 1 mmol/l cholesterol 1.20 (95% confidence 1.16 to 1.24) and 1.48 (1.43 to 1.53), respectively). Haemorrhagic stroke showed an inverse association in fully adjusted models (0.91, 0.87 to 0.95). This inverse association was confined to participants with hypertension. When stratified by concentration of gamma glutamyl transferase (GGT), an indicator of alcohol consumption, the association was not seen in participants with low concentrations of GGT, and it was independent of hypertension in those with high concentrations of GGT (> 80 U/l).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16757495      PMCID: PMC1488755          DOI: 10.1136/bmj.38855.610324.80

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  27 in total

1.  Those confounded vitamins: what can we learn from the differences between observational versus randomised trial evidence?

Authors:  Debbie A Lawlor; George Davey Smith; Devi Kundu; K Richard Bruckdorfer; Shah Ebrahim
Journal:  Lancet       Date:  2004-05-22       Impact factor: 79.321

2.  Serum cholesterol and hemorrhagic stroke in the Honolulu Heart Program.

Authors:  K Yano; D M Reed; C J MacLean
Journal:  Stroke       Date:  1989-11       Impact factor: 7.914

3.  Trends for coronary heart disease and stroke and their risk factors in Japan.

Authors:  T Shimamoto; Y Komachi; H Inada; M Doi; H Iso; S Sato; A Kitamura; M Iida; M Konishi; N Nakanishi
Journal:  Circulation       Date:  1989-03       Impact factor: 29.690

4.  Alcohol consumption and mortality from all causes, coronary heart disease, and stroke: results from a prospective cohort study of scottish men with 21 years of follow up.

Authors:  C L Hart; G D Smith; D J Hole; V M Hawthorne
Journal:  BMJ       Date:  1999-06-26

5.  Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group.

Authors:  J D Neaton; H Blackburn; D Jacobs; L Kuller; D J Lee; R Sherwin; J Shih; J Stamler; D Wentworth
Journal:  Arch Intern Med       Date:  1992-07

6.  Prolonged infection with hepatitis B virus and association between low blood cholesterol concentration and liver cancer.

Authors:  Z Chen; A Keech; R Collins; B Slavin; J Chen; T C Campbell; R Peto
Journal:  BMJ       Date:  1993-04-03

7.  Do changes in cardiovascular risk factors explain changes in mortality from stroke in Finland?

Authors:  E Vartiainen; C Sarti; J Tuomilehto; K Kuulasmaa
Journal:  BMJ       Date:  1995-04-08

8.  Hypertension, cigarette smoking, and the decline in stroke incidence in eastern Finland.

Authors:  J Tuomilehto; R Bonita; A Stewart; A Nissinen; J T Salonen
Journal:  Stroke       Date:  1991-01       Impact factor: 7.914

9.  Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Prospective studies collaboration.

Authors: 
Journal:  Lancet       Date:  1995 Dec 23-30       Impact factor: 79.321

10.  Serum total cholesterol and mortality. Confounding factors and risk modification in Japanese-American men.

Authors:  C Iribarren; D M Reed; C M Burchfiel; J H Dwyer
Journal:  JAMA       Date:  1995-06-28       Impact factor: 56.272

View more
  36 in total

1.  Cholesterol and risk of stroke: the Japanese comparison.

Authors:  Malcolm E Kendrick
Journal:  BMJ       Date:  2006-07-15

2.  Cholesterol and risk of stroke: study lumps apples and oranges.

Authors:  Bruce Ovbiagele
Journal:  BMJ       Date:  2006-07-15

Review 3.  [Statins in the secondary prevention of ictus in the community].

Authors:  Luis Castilla-Guerra; Manuel Balbuena García; María Carmen Fernández-Moreno
Journal:  Aten Primaria       Date:  2007-07       Impact factor: 1.137

4.  Statin Therapy and Risk of Intracranial Hemorrhage in Patients with Ischemic Stroke.

Authors:  Matilda Florentin; Moses S Elisaf
Journal:  Drug Saf       Date:  2017-10       Impact factor: 5.606

5.  Blood pressure, cholesterol and cardiovascular disease in Thailand.

Authors:  Panrasri Khonputsa; J Lennert Veerman; Prin Vathesatogkit; Somlax Vanavanan; Stephen Lim; Melanie Bertram; Theo Vos; Wipa Ratanachaiwong; Sukit Yamwong
Journal:  Heart Asia       Date:  2010-07-11

6.  A pooled analysis of the association of isolated low levels of high-density lipoprotein cholesterol with cardiovascular mortality in Japan.

Authors:  Takumi Hirata; Daisuke Sugiyama; Shin-Ya Nagasawa; Yoshitaka Murakami; Shigeyuki Saitoh; Akira Okayama; Hiroyasu Iso; Fujiko Irie; Toshimi Sairenchi; Yoshihiro Miyamoto; Michiko Yamada; Shizukiyo Ishikawa; Katsuyuki Miura; Hirotsugu Ueshima; Tomonori Okamura
Journal:  Eur J Epidemiol       Date:  2016-10-05       Impact factor: 8.082

7.  [Secondary prevention of stroke according to PRoFESS and SPARCL].

Authors:  D Sander; T Etgen
Journal:  Internist (Berl)       Date:  2009-11       Impact factor: 0.743

8.  Atorvastatin in stroke: a review of SPARCL and subgroup analysis.

Authors:  Branko N Huisa; Andrew B Stemer; Justin A Zivin
Journal:  Vasc Health Risk Manag       Date:  2010-04-15

Review 9.  Statins for the primary prevention of cardiovascular disease.

Authors:  Fiona Taylor; Mark D Huffman; Ana Filipa Macedo; Theresa H M Moore; Margaret Burke; George Davey Smith; Kirsten Ward; Shah Ebrahim
Journal:  Cochrane Database Syst Rev       Date:  2013-01-31

10.  Silent microbleeds and old hematomas in spontaneous cerebral hemorrhages.

Authors:  Jae-Bum Lim; Ealmaan Kim
Journal:  J Korean Neurosurg Soc       Date:  2009-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.